Core Viewpoint - Solo Brands, Inc. is appealing the NYSE Regulation's decision to delist its Class A common stock due to "abnormally low" price levels, with the aim of restoring compliance with NYSE listing standards [1][2][4]. Group 1: Company Actions and Status - The NYSE Regulation staff determined that Solo Brands' Class A common stock was unsuitable for listing, leading to a trading halt and current quotation on the OTC Pink Market under the symbol "DTCB" [2][3]. - The company plans to continue operating in compliance with SEC regulations and NYSE listing requirements during the appeal period [5]. - If the appeal is successful, trading of the Class A common stock may resume on the NYSE [3]. Group 2: Company Perspective - The interim President and CEO of Solo Brands stated that the current trading price and market capitalization do not reflect the company's value, prompting the appeal [4]. - The company is committed to executing action plans, including a reverse stock split, to restore compliance with NYSE standards [4]. Group 3: Company Overview - Solo Brands is headquartered in Grapevine, TX, and operates a portfolio of lifestyle brands, including Solo Stove, Chubbies, Isle, and Oru, focusing on innovative outdoor and apparel products [6].

Core Viewpoint - Jin Medical International Ltd. has received a deficiency letter from Nasdaq regarding non-compliance with the minimum bid price requirement for its ordinary shares, which must be at least $1.00 per share for continued listing on The Nasdaq Capital Market [1][2]. Compliance Status - The deficiency notice does not immediately affect the listing status of the ordinary shares, and the company has a compliance period of 180 calendar days, until October 29, 2025, to regain compliance [2][3]. - If the closing bid price reaches or exceeds $1.00 for a minimum of 10 consecutive business days before the deadline, the company will be notified of compliance [2]. Reverse Stock Split - The company may implement a reverse stock split to regain compliance, which must be completed no later than ten business days prior to October 29, 2025 [2][4]. - If the company fails to regain compliance within the initial 180-day period, it may be eligible for an additional compliance period, provided it meets other listing requirements [3][4]. Company Overview - Jin Medical International Ltd. was founded in 2006 and is headquartered in Changzhou, Jiangsu Province, China, focusing on designing, developing, manufacturing, and marketing wheelchairs and living aids for people with disabilities and the elderly [5]. - The company operates two manufacturing plants totaling approximately 230,000 square feet and is establishing a new facility of 430,000 square feet in Chuzhou, Anhui Province [5]. - Jin Medical has over 40 distributors in China and more than 20 international distributors, with a significant portion of its wheelchair products sold to Japan and China [5].

Core Points - TransCode Therapeutics has announced a 1-for-28 reverse stock split effective at 12:01 a.m. Eastern Standard Time on May 15, 2025, to increase the per share trading price and meet Nasdaq listing requirements [1][2] - The reverse stock split will reduce the number of outstanding shares from approximately 23,341,336 to about 833,620 shares, with no fractional shares issued [2] - The company's CUSIP number will change to 89357L 501 as of the effective time of the reverse stock split [4] Company Overview - TransCode Therapeutics is a clinical-stage oncology company focused on treating metastatic disease through RNA therapeutics, utilizing its proprietary TTX nanoparticle platform [5] - The lead therapeutic candidate, TTX-MC138, targets metastatic tumors that overexpress microRNA-10b, a biomarker associated with metastasis [5] - The company is also developing a portfolio of first-in-class RNA therapeutic candidates aimed at overcoming RNA delivery challenges to access novel genetic targets for cancer treatment [5]

Core Insights - The marijuana sector continues to face significant challenges, leading to a lack of investor interest, particularly as cannabis remains illegal at the federal level in the U.S. [1] - Tilray Brands has experienced a substantial decline in its stock value, losing over 26% in April and trading under $1, indicating a prolonged downward trend [1][4] - The company reported a 1% year-over-year decline in net revenue for fiscal Q3 2025, totaling just under $186 million, and posted a non-GAAP loss of $2.9 million compared to a profit of $885,000 in the same period the previous year [2][4] Financial Performance - Tilray's management has reduced its revenue guidance for 2025, now expecting $850 million to $900 million, down from a previous estimate of $950 million to $1 billion [4] - The company is considering a reverse stock split with a proposed ratio of 1-to-10 to 1-to-20 to boost its stock price, which will be voted on in a special shareholders' meeting on June 10 [5] Diversification Efforts - In an attempt to diversify, Tilray has been acquiring craft breweries, as beer has broader market appeal and is not subject to the same regulatory challenges as cannabis [7] - However, the beer market has also faced challenges, with consumption hitting a four-decade low in 2024, raising doubts about whether this strategy will improve Tilray's fortunes [8] Market Outlook - There are currently no clear catalysts for Tilray's recovery, with the only potential being the decriminalization of cannabis in the U.S., which appears unlikely in the near term [9]

Split designed to achieve compliance with Nasdaq minimum bid price requirementsBOSTON, May 2, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that its Board of Directors has approved a 1-for-28 reverse stock split. The reverse stock split was approved by TransCode's stockholders on May 2, 2025, and is intended to increase the per share trading price ...

SCOTTSDALE, Ariz., April 30, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced that it will effect a 1-for-20 reverse stock split (“Reverse Stock Split”) of its Class A common stock, par value $0.001 per share (“Class A Common Stock”) and Class B common stock, par value $0.001 per share (“Class B Common Stock”, together with the Class A Common Stock, the “Common Stock”), that will become effective on May 2, 2025, at 12:01 a.m. Eastern Time. The C ...

Core Points - Snow Lake Resources Ltd. will implement a 1-for-13 reverse stock split effective on May 2, 2025, to comply with Nasdaq's minimum bid price requirement of $1.00 [1][2] - The reverse stock split will reduce the number of issued and outstanding common shares from approximately 101,704,516 to about 7,823,360 [4] - The reverse stock split will not change the par value of the common shares or the authorized number of shares, and it will affect all shareholders uniformly [3][4] Company Information - Snow Lake Resources Ltd., operating as Snow Lake Energy, is a Canadian mineral exploration company listed on Nasdaq under the symbol LITM, focusing on critical mineral and clean energy projects [8] - The company has exploration stage projects including the Pine Ridge Uranium project in Wyoming, USA, and the Engo Valley Uranium Project in Namibia, along with additional projects in Manitoba [8]

Core Viewpoint - Easterly Government Properties reported quarterly results that were generally in line with expectations, but investor sentiment is overshadowed by earlier disappointing news regarding dividend cuts and stock splits [1][3]. Company Performance - The company reported first-quarter funds from operations (FFO) of $0.73 per share on revenue of $78.7 million, with FFO meeting expectations while revenue fell short by $1.3 million [4]. - Following the announcement of a 32% reduction in quarterly dividends and a 1-for-2.5 reverse stock split, shares dropped by 15% [3]. Industry Context - Easterly, as a REIT focused on government properties, is affected by the Department of Government Efficiency's initiatives to reduce federal spending, including real estate [2]. - The CEO expressed optimism that the company could benefit from government cost-saving efforts, indicating a potential shift towards partnerships with private real estate owners [5]. Investor Sentiment - The company is currently viewed as a "show me" stock, with investors advised to monitor it closely due to the recent volatility and changes in dividend policy [6].

Core Viewpoint - FOXO Technologies Inc. has completed a 1 for 10 reverse stock split of its outstanding common stock, effective April 28, 2025, with trading resuming on a post-split basis on April 29, 2025 [1][2][3]. Group 1: Reverse Stock Split Details - The reverse stock split consolidates every 10 shares of common stock into one share, maintaining the nominal par value per share at $0.0001 [2]. - The number of shares will decrease from approximately 38.7 million to approximately 3.87 million post-split [3]. - All outstanding preferred shares, stock options, warrants, and equity incentive plans will be adjusted accordingly, with the number of shares divided by 10 and the exercise or conversion price multiplied by 10 [4]. Group 2: Administrative Aspects - Continental Stock Transfer & Trust Company has been retained as the exchange agent for the reverse stock split, providing instructions for stockholders of record [5]. - Stockholders with shares held through brokers will have their positions automatically adjusted without needing to take action [5]. - The reverse split was approved by the Company's directors on April 17, 2025, following a majority shareholder resolution on November 29, 2024 [6]. Group 3: Company Overview - FOXO Technologies Inc. operates three subsidiaries: Rennova Community Health, which owns Scott County Community Hospital, Myrtle Recovery Centers, a behavioral health facility, and Foxo Labs, a biotechnology company focused on health and lifespan improvement [7][8].

Management remains focused on improving profitability and expanding margins by modernizing its fleet, leveraging partnership with Delta and delivering premium solutions for every customer journeyATLANTA, April 25, 2025 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE: UP) ("Wheels Up") today announced that it received a notice from the New York Stock Exchange (the "NYSE") on April 22, 2025 that the average closing price per share of its common stock did not exceed $1.00 over a 30 consecutive trading-day peri ...